Ireland - English - HPRA (Health Products Regulatory Authority)

upjohn eesv - alprazolam - tablet - 1 milligram(s) - benzodiazepine derivatives; alprazolam

Ireland - English - HPRA (Health Products Regulatory Authority)

upjohn eesv - alprazolam - tablet - 250 microgram(s) - benzodiazepine derivatives; alprazolam

Ireland - English - HPRA (Health Products Regulatory Authority)

upjohn eesv - alprazolam - tablet - 500 microgram(s) - benzodiazepine derivatives; alprazolam

Malta - English - Malta Medicines Authority

viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - film-coated tablet - sildenafil 25 mg - urologicals

Malta - English - Malta Medicines Authority

viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - film-coated tablet - sildenafil 50 mg - urologicals

Malta - English - Malta Medicines Authority

viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - film-coated tablet - sildenafil 100 mg - urologicals

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - medroxyprogesterone acetate, quantity: 500 mg - tablet, uncoated - excipient ingredients: gelatin; sodium benzoate; purified water; docusate sodium; sodium starch glycollate; magnesium stearate; microcrystalline cellulose; maize starch; isopropyl alcohol; macrogol 400 - 1. carcinoma: palliative treatment of recurrent and/or metastatic breast or renal cell cancer and of inoperable recurrent or metastatic endometrial carcinoma. 2. endometriosis: for use in the treatment of visually proven (laparoscopy) endometriosis where the required end-point of treatment is pregnancy, or for the control of symptoms when surgery is contraindicated or has been unsuccessful. 3. secondary amenorrhoea proven not due to pregnancy: in amenorrhoea associated with a poorly developed proliferative endometrium, conventional oestrogen therapy may be employed in conjunction with medroxyprogesterone acetate. 4. abnormal uterine bleeding: in the absence of organic pathology. 5. adjunct to oestrogen therapy: combination hormone replacement therapy should only be used in non-hysterectomised women.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone; ziprasidone hydrochloride monohydrate 67.95mg equivalent to 60 mg ziprasidone; ziprasidone hydrochloride monohydrate 90.6mg equivalent to 80 mg ziprasidone - capsule - active: ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch active: ziprasidone hydrochloride monohydrate 67.95mg equivalent to 60 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch active: ziprasidone hydrochloride monohydrate 90.6mg equivalent to 80 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch - ziprasidone is also indicated as a monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar 1 disorder.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 22.652mg equivalent to 20 mg ziprasidone - capsule - 20 mg - active: ziprasidone hydrochloride monohydrate 22.652mg equivalent to 20 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch tekprint black sw-9008 - ziprasidone is indicated for the treatment of acute schizophrenia, and maintenance or continuation therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone - capsule - 40 mg - active: ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch tekprint black sw-9008 - ziprasidone is indicated for the treatment of acute schizophrenia, and maintenance or continuation therapy.